JAL Therapeutics Revenue
Biotechnology Research • 
United States • 1-10 Employees
$
JAL Therapeutics revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Key Contact at JAL Therapeutics
Kensaku Nakayama
Chief Executive Officer
Company overview
| Headquarters | United States |
| Phone number | +19492473250 |
| Website | |
| Employees | 1-10 |
| Socials |
About JAL Therapeutics
Preclinical-stage life sciences company with a mission to treat and prevent Alzheimer’s disease, dementia, and other chronic conditions.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
JAL Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
JAL Therapeutics has never raised funding before.
Pakistan
Spain
Belgium
Cocos (Keeling) IslandsFrequently asked questions
JAL Therapeutics is located in US.
You can reach JAL Therapeutics at +19492473250.
JAL Therapeutics generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.
JAL Therapeutics has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
JAL Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
